Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007107
Filing Date
2015-08-12
Accepted
2015-08-12 16:20:52
Documents
14
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clcd-10q_20150630.htm 10-Q 1133835
2 EX-4.1 clcd-ex41_148.htm EX-4.1 11597
3 EX-31.1 clcd-ex311_2015063015.htm EX-31.1 8132
4 EX-31.2 clcd-ex312_2015063014.htm EX-31.2 8132
5 EX-32.1 clcd-ex321_2015063013.htm EX-32.1 5910
6 EX-32.2 clcd-ex322_2015063012.htm EX-32.2 5832
7 GRAPHIC g201508111914566222711.jpg GRAPHIC 74861
8 GRAPHIC g201508111914567782712.jpg GRAPHIC 73129
  Complete submission text file 0001564590-15-007107.txt   4269314

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT clcd-20150630.xml EX-101.INS 786740
10 XBRL TAXONOMY EXTENSION SCHEMA clcd-20150630.xsd EX-101.SCH 30399
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcd-20150630_cal.xml EX-101.CAL 26299
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcd-20150630_def.xml EX-101.DEF 118541
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcd-20150630_lab.xml EX-101.LAB 259161
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcd-20150630_pre.xml EX-101.PRE 197252
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Filer) CIK: 0001348649 (see all company filings)

EIN.: 203419541 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37358 | Film No.: 151047249
SIC: 2834 Pharmaceutical Preparations